|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14-12-09 | Cubist Pharmaceuticals : sales force seen as potential boon for Merck intestinal drug | RE |
| 14-12-09 | Cubist Pharmaceuticals : Merck says still plans to buy Cubist, despite patent setback | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 0 | ||
| +1.00% | +4.39% | +43.53% | -0.12% | 79.68B | ||
| +0.97% | +3.30% | -2.19% | +26.99% | 50.61B | ||
| -1.22% | -2.62% | +15.13% | +167.13% | 48.81B | ||
| -0.14% | +3.87% | -49.17% | -47.79% | 46.91B | ||
| +0.85% | +2.12% | +55.82% | -23.03% | 30.86B | ||
| -0.03% | +18.18% | +136.71% | -37.28% | 25.42B | ||
| -0.21% | +1.81% | +40.38% | +82.80% | 24.48B | ||
| -0.74% | -0.53% | -1.72% | +191.20% | 21.2B | ||
| -3.14% | -1.92% | +61.19% | +161.38% | 16.39B | ||
| Average | -0.31% | +3.80% | +33.30% | +57.92% | 34.44B | |
| Weighted average by Cap. | +0.04% | +3.46% | +25.97% | +41.64% |
Historical Quotes: Cubist Pharmaceuticals Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- Stock
- Quotes Cubist Pharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
















